nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA14—prostate gland—urinary bladder cancer	0.0153	0.0747	CbGeAlD
Brinzolamide—CA5A—female reproductive system—urinary bladder cancer	0.015	0.0736	CbGeAlD
Brinzolamide—CA14—seminal vesicle—urinary bladder cancer	0.0129	0.0632	CbGeAlD
Brinzolamide—CA7—renal system—urinary bladder cancer	0.0125	0.0611	CbGeAlD
Brinzolamide—CYP3A4—urine—urinary bladder cancer	0.011	0.0538	CbGeAlD
Brinzolamide—CA5B—prostate gland—urinary bladder cancer	0.0107	0.0523	CbGeAlD
Brinzolamide—CA9—female reproductive system—urinary bladder cancer	0.00878	0.043	CbGeAlD
Brinzolamide—CA12—renal system—urinary bladder cancer	0.00811	0.0397	CbGeAlD
Brinzolamide—CA4—prostate gland—urinary bladder cancer	0.00737	0.0361	CbGeAlD
Brinzolamide—CA5B—urethra—urinary bladder cancer	0.00715	0.035	CbGeAlD
Brinzolamide—CA12—female reproductive system—urinary bladder cancer	0.0065	0.0318	CbGeAlD
Brinzolamide—CA1—renal system—urinary bladder cancer	0.00643	0.0315	CbGeAlD
Brinzolamide—CA4—seminal vesicle—urinary bladder cancer	0.00623	0.0305	CbGeAlD
Brinzolamide—CA2—prostate gland—urinary bladder cancer	0.00611	0.0299	CbGeAlD
Brinzolamide—CA5B—female reproductive system—urinary bladder cancer	0.00583	0.0285	CbGeAlD
Brinzolamide—CA5B—vagina—urinary bladder cancer	0.00527	0.0258	CbGeAlD
Brinzolamide—CA2—seminal vesicle—urinary bladder cancer	0.00517	0.0253	CbGeAlD
Brinzolamide—CA1—female reproductive system—urinary bladder cancer	0.00515	0.0252	CbGeAlD
Brinzolamide—CA4—renal system—urinary bladder cancer	0.00502	0.0246	CbGeAlD
Brinzolamide—CA4—urethra—urinary bladder cancer	0.00493	0.0242	CbGeAlD
Brinzolamide—CA2—epithelium—urinary bladder cancer	0.00449	0.022	CbGeAlD
Brinzolamide—CA2—smooth muscle tissue—urinary bladder cancer	0.00433	0.0212	CbGeAlD
Brinzolamide—CA2—renal system—urinary bladder cancer	0.00417	0.0204	CbGeAlD
Brinzolamide—CA4—female reproductive system—urinary bladder cancer	0.00402	0.0197	CbGeAlD
Brinzolamide—CA5B—lymph node—urinary bladder cancer	0.00341	0.0167	CbGeAlD
Brinzolamide—CA2—female reproductive system—urinary bladder cancer	0.00334	0.0163	CbGeAlD
Brinzolamide—CA2—vagina—urinary bladder cancer	0.00302	0.0148	CbGeAlD
Brinzolamide—CA1—lymph node—urinary bladder cancer	0.00301	0.0147	CbGeAlD
Brinzolamide—CYP3A4—renal system—urinary bladder cancer	0.00269	0.0132	CbGeAlD
Brinzolamide—CA4—lymph node—urinary bladder cancer	0.00235	0.0115	CbGeAlD
Brinzolamide—CYP3A4—female reproductive system—urinary bladder cancer	0.00215	0.0105	CbGeAlD
Brinzolamide—CA2—lymph node—urinary bladder cancer	0.00195	0.00955	CbGeAlD
Brinzolamide—Dyspnoea—Etoposide—urinary bladder cancer	0.000788	0.00121	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—urinary bladder cancer	0.000786	0.00121	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000786	0.00121	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000785	0.00121	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—urinary bladder cancer	0.000783	0.0012	CcSEcCtD
Brinzolamide—Vomiting—Thiotepa—urinary bladder cancer	0.000783	0.0012	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—urinary bladder cancer	0.000777	0.00119	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—urinary bladder cancer	0.000777	0.00119	CcSEcCtD
Brinzolamide—Rash—Thiotepa—urinary bladder cancer	0.000776	0.00119	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—urinary bladder cancer	0.000776	0.00119	CcSEcCtD
Brinzolamide—Dermatitis—Thiotepa—urinary bladder cancer	0.000775	0.00119	CcSEcCtD
Brinzolamide—Headache—Thiotepa—urinary bladder cancer	0.000771	0.00118	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—urinary bladder cancer	0.000769	0.00118	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000763	0.00117	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—urinary bladder cancer	0.000762	0.00117	CcSEcCtD
Brinzolamide—Pain—Etoposide—urinary bladder cancer	0.000756	0.00116	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000755	0.00116	CcSEcCtD
Brinzolamide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00075	0.00115	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000745	0.00114	CcSEcCtD
Brinzolamide—Asthenia—Gemcitabine—urinary bladder cancer	0.000743	0.00114	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—urinary bladder cancer	0.00074	0.00114	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000736	0.00113	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000735	0.00113	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—urinary bladder cancer	0.000733	0.00113	CcSEcCtD
Brinzolamide—Pruritus—Gemcitabine—urinary bladder cancer	0.000733	0.00113	CcSEcCtD
Brinzolamide—Nausea—Thiotepa—urinary bladder cancer	0.000731	0.00112	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—urinary bladder cancer	0.000731	0.00112	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—urinary bladder cancer	0.000729	0.00112	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000729	0.00112	CcSEcCtD
Brinzolamide—Pruritus—Fluorouracil—urinary bladder cancer	0.00072	0.00111	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000719	0.0011	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—urinary bladder cancer	0.000719	0.0011	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—urinary bladder cancer	0.000718	0.0011	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000711	0.00109	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—urinary bladder cancer	0.00071	0.00109	CcSEcCtD
Brinzolamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000708	0.00109	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—urinary bladder cancer	0.000702	0.00108	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—urinary bladder cancer	0.000699	0.00107	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000699	0.00107	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—urinary bladder cancer	0.000697	0.00107	CcSEcCtD
Brinzolamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000697	0.00107	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—urinary bladder cancer	0.000695	0.00107	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000694	0.00107	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—urinary bladder cancer	0.000692	0.00106	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—urinary bladder cancer	0.000692	0.00106	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000692	0.00106	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000689	0.00106	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000687	0.00106	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000686	0.00105	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000684	0.00105	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00068	0.00104	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—urinary bladder cancer	0.000678	0.00104	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—urinary bladder cancer	0.000676	0.00104	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—urinary bladder cancer	0.000675	0.00104	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—urinary bladder cancer	0.000673	0.00103	CcSEcCtD
Brinzolamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000673	0.00103	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—urinary bladder cancer	0.000672	0.00103	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000672	0.00103	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00066	0.00101	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—urinary bladder cancer	0.000659	0.00101	CcSEcCtD
Brinzolamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000658	0.00101	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—urinary bladder cancer	0.000657	0.00101	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—urinary bladder cancer	0.000653	0.001	CcSEcCtD
Brinzolamide—Rash—Gemcitabine—urinary bladder cancer	0.000653	0.001	CcSEcCtD
Brinzolamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000652	0.001	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—urinary bladder cancer	0.000652	0.001	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000651	0.001	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—urinary bladder cancer	0.00065	0.001	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—urinary bladder cancer	0.000649	0.000997	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—urinary bladder cancer	0.000649	0.000997	CcSEcCtD
Brinzolamide—Headache—Gemcitabine—urinary bladder cancer	0.000649	0.000997	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000647	0.000995	CcSEcCtD
Brinzolamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000647	0.000995	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000647	0.000994	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000642	0.000987	CcSEcCtD
Brinzolamide—Rash—Fluorouracil—urinary bladder cancer	0.000642	0.000986	CcSEcCtD
Brinzolamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000641	0.000986	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000641	0.000984	CcSEcCtD
Brinzolamide—Headache—Fluorouracil—urinary bladder cancer	0.000638	0.00098	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000637	0.00098	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000636	0.000977	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—urinary bladder cancer	0.000635	0.000977	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—urinary bladder cancer	0.000634	0.000975	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000634	0.000975	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—urinary bladder cancer	0.000633	0.000973	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000633	0.000972	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—urinary bladder cancer	0.00063	0.000968	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000629	0.000966	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—urinary bladder cancer	0.000628	0.000965	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—urinary bladder cancer	0.000626	0.000961	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—urinary bladder cancer	0.000623	0.000958	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000622	0.000956	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—urinary bladder cancer	0.000616	0.000947	CcSEcCtD
Brinzolamide—Nausea—Gemcitabine—urinary bladder cancer	0.000615	0.000945	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—urinary bladder cancer	0.000614	0.000943	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—urinary bladder cancer	0.000612	0.00094	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—urinary bladder cancer	0.000611	0.000939	CcSEcCtD
Brinzolamide—Rash—Cisplatin—urinary bladder cancer	0.000609	0.000935	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—urinary bladder cancer	0.000608	0.000934	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—urinary bladder cancer	0.000607	0.000933	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—urinary bladder cancer	0.000607	0.000933	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000605	0.00093	CcSEcCtD
Brinzolamide—Nausea—Fluorouracil—urinary bladder cancer	0.000605	0.000929	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000603	0.000927	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000602	0.000925	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000602	0.000925	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000599	0.000921	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—urinary bladder cancer	0.000598	0.00092	CcSEcCtD
Brinzolamide—Tension—Epirubicin—urinary bladder cancer	0.000596	0.000916	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000595	0.000914	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—urinary bladder cancer	0.00059	0.000906	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—urinary bladder cancer	0.000587	0.000903	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—urinary bladder cancer	0.000586	0.0009	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—urinary bladder cancer	0.000585	0.000899	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—urinary bladder cancer	0.000585	0.000898	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000584	0.000897	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000583	0.000896	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—urinary bladder cancer	0.000583	0.000896	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000582	0.000894	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000577	0.000886	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—urinary bladder cancer	0.000573	0.000881	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—urinary bladder cancer	0.000572	0.000879	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—urinary bladder cancer	0.00057	0.000877	CcSEcCtD
Brinzolamide—Cough—Methotrexate—urinary bladder cancer	0.000566	0.00087	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—urinary bladder cancer	0.000565	0.000869	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000563	0.000866	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—urinary bladder cancer	0.000562	0.000864	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—urinary bladder cancer	0.000562	0.000863	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—urinary bladder cancer	0.000562	0.000863	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—urinary bladder cancer	0.000558	0.000858	CcSEcCtD
Brinzolamide—Rash—Etoposide—urinary bladder cancer	0.000557	0.000857	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—urinary bladder cancer	0.000557	0.000856	CcSEcCtD
Brinzolamide—Headache—Etoposide—urinary bladder cancer	0.000554	0.000851	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—urinary bladder cancer	0.000554	0.000851	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—urinary bladder cancer	0.000552	0.000849	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—urinary bladder cancer	0.000552	0.000849	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—urinary bladder cancer	0.000552	0.000849	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—urinary bladder cancer	0.000551	0.000847	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00055	0.000846	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000549	0.000843	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—urinary bladder cancer	0.000548	0.000842	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—urinary bladder cancer	0.000546	0.000839	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—urinary bladder cancer	0.000546	0.000839	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—urinary bladder cancer	0.000546	0.000838	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—urinary bladder cancer	0.000544	0.000835	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00054	0.00083	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—urinary bladder cancer	0.000537	0.000825	CcSEcCtD
Brinzolamide—Cough—Epirubicin—urinary bladder cancer	0.00053	0.000814	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—urinary bladder cancer	0.00053	0.000814	CcSEcCtD
Brinzolamide—Infection—Methotrexate—urinary bladder cancer	0.000526	0.000809	CcSEcCtD
Brinzolamide—Nausea—Etoposide—urinary bladder cancer	0.000525	0.000807	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—urinary bladder cancer	0.000524	0.000806	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000521	0.000801	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000519	0.000798	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—urinary bladder cancer	0.000517	0.000794	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—urinary bladder cancer	0.000517	0.000794	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—urinary bladder cancer	0.000517	0.000794	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—urinary bladder cancer	0.000516	0.000793	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—urinary bladder cancer	0.000514	0.000791	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000513	0.000789	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—urinary bladder cancer	0.000511	0.000785	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—urinary bladder cancer	0.000507	0.000779	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—urinary bladder cancer	0.000506	0.000777	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—urinary bladder cancer	0.000505	0.000776	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—urinary bladder cancer	0.000497	0.000763	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—urinary bladder cancer	0.000495	0.00076	CcSEcCtD
Brinzolamide—Infection—Epirubicin—urinary bladder cancer	0.000492	0.000757	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—urinary bladder cancer	0.00049	0.000753	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000486	0.000747	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—urinary bladder cancer	0.000485	0.000745	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—urinary bladder cancer	0.000484	0.000743	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000483	0.000741	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—urinary bladder cancer	0.000481	0.00074	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—urinary bladder cancer	0.000479	0.000736	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—urinary bladder cancer	0.000478	0.000735	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—urinary bladder cancer	0.000478	0.000735	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—urinary bladder cancer	0.000478	0.000735	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000476	0.000731	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000475	0.00073	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—urinary bladder cancer	0.000473	0.000726	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000472	0.000726	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—urinary bladder cancer	0.000471	0.000724	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000468	0.000719	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000466	0.000716	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—urinary bladder cancer	0.000463	0.000712	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.00046	0.000707	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000457	0.000703	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—urinary bladder cancer	0.000457	0.000702	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—urinary bladder cancer	0.000456	0.0007	CcSEcCtD
Brinzolamide—Pain—Methotrexate—urinary bladder cancer	0.000453	0.000696	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000452	0.000694	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00045	0.000691	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—urinary bladder cancer	0.000448	0.000689	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000448	0.000688	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000445	0.000684	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000445	0.000684	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000442	0.000679	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—urinary bladder cancer	0.000441	0.000677	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000436	0.000671	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000436	0.00067	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000431	0.000662	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—urinary bladder cancer	0.000429	0.000658	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000428	0.000658	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—urinary bladder cancer	0.000427	0.000657	CcSEcCtD
Brinzolamide—Pain—Epirubicin—urinary bladder cancer	0.000424	0.000651	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—urinary bladder cancer	0.000421	0.000647	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000418	0.000642	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—urinary bladder cancer	0.000415	0.000637	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000412	0.000633	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000409	0.000628	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000408	0.000628	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000408	0.000626	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000404	0.00062	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000399	0.000613	CcSEcCtD
Brinzolamide—CA14—Metabolism—NAT2—urinary bladder cancer	0.000397	0.00274	CbGpPWpGaD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000396	0.000608	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000395	0.000608	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—urinary bladder cancer	0.000394	0.000605	CcSEcCtD
Brinzolamide—CA9—Metabolism—GSTO2—urinary bladder cancer	0.000393	0.00271	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NAT1—urinary bladder cancer	0.000393	0.00271	CbGpPWpGaD
Brinzolamide—Pain—Doxorubicin—urinary bladder cancer	0.000392	0.000603	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00039	0.0006	CcSEcCtD
Brinzolamide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000387	0.00267	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000387	0.00267	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NAT2—urinary bladder cancer	0.000387	0.00267	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NAT2—urinary bladder cancer	0.000387	0.00267	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000384	0.00265	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000382	0.00264	CbGpPWpGaD
Brinzolamide—Asthenia—Methotrexate—urinary bladder cancer	0.00038	0.000584	CcSEcCtD
Brinzolamide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000379	0.00261	CbGpPWpGaD
Brinzolamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000378	0.000581	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—urinary bladder cancer	0.000375	0.000576	CcSEcCtD
Brinzolamide—CA12—Metabolism—TYMP—urinary bladder cancer	0.00037	0.00255	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000369	0.00255	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000369	0.00254	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000365	0.000561	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000364	0.00056	CcSEcCtD
Brinzolamide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000363	0.0025	CbGpPWpGaD
Brinzolamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000362	0.000557	CcSEcCtD
Brinzolamide—CA7—Metabolism—NAT2—urinary bladder cancer	0.000361	0.00249	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NAT2—urinary bladder cancer	0.000361	0.00249	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.00036	0.00248	CbGpPWpGaD
Brinzolamide—Asthenia—Epirubicin—urinary bladder cancer	0.000356	0.000546	CcSEcCtD
Brinzolamide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000354	0.00244	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000354	0.00244	CbGpPWpGaD
Brinzolamide—Pruritus—Epirubicin—urinary bladder cancer	0.000351	0.000539	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—urinary bladder cancer	0.00035	0.000538	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.00035	0.00242	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000349	0.00241	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000349	0.0024	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000348	0.0024	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—RRM2—urinary bladder cancer	0.000343	0.00236	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.000339	0.00234	CbGpPWpGaD
Brinzolamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000339	0.000521	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000338	0.000519	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—urinary bladder cancer	0.000337	0.000517	CcSEcCtD
Brinzolamide—CA12—Metabolism—NAT2—urinary bladder cancer	0.000335	0.00231	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—RRM2—urinary bladder cancer	0.000334	0.0023	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—RRM2—urinary bladder cancer	0.000334	0.0023	CbGpPWpGaD
Brinzolamide—Rash—Methotrexate—urinary bladder cancer	0.000334	0.000513	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—urinary bladder cancer	0.000334	0.000513	CcSEcCtD
Brinzolamide—Headache—Methotrexate—urinary bladder cancer	0.000332	0.00051	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000329	0.000506	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—urinary bladder cancer	0.000328	0.000504	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000324	0.000499	CcSEcCtD
Brinzolamide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000324	0.00224	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000319	0.0022	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ENO2—urinary bladder cancer	0.000317	0.00219	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—HPGDS—urinary bladder cancer	0.000317	0.00219	CbGpPWpGaD
Brinzolamide—Vomiting—Epirubicin—urinary bladder cancer	0.000315	0.000484	CcSEcCtD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000315	0.00217	CbGpPWpGaD
Brinzolamide—Nausea—Methotrexate—urinary bladder cancer	0.000315	0.000483	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000314	0.000482	CcSEcCtD
Brinzolamide—Rash—Epirubicin—urinary bladder cancer	0.000312	0.00048	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—urinary bladder cancer	0.000312	0.00048	CcSEcCtD
Brinzolamide—CA7—Metabolism—RRM2—urinary bladder cancer	0.000312	0.00215	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000312	0.00215	CbGpPWpGaD
Brinzolamide—Headache—Epirubicin—urinary bladder cancer	0.00031	0.000477	CcSEcCtD
Brinzolamide—CA6—Metabolism—HPGDS—urinary bladder cancer	0.000309	0.00213	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—HPGDS—urinary bladder cancer	0.000309	0.00213	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ENO2—urinary bladder cancer	0.000309	0.00213	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ENO2—urinary bladder cancer	0.000309	0.00213	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTT1—urinary bladder cancer	0.000308	0.00212	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000306	0.00211	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000304	0.0021	CbGpPWpGaD
Brinzolamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000303	0.000466	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000303	0.00209	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTT1—urinary bladder cancer	0.0003	0.00207	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTT1—urinary bladder cancer	0.0003	0.00207	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.000298	0.00206	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000295	0.00204	CbGpPWpGaD
Brinzolamide—Nausea—Epirubicin—urinary bladder cancer	0.000294	0.000452	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000292	0.000448	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—urinary bladder cancer	0.000289	0.000444	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000289	0.000444	CcSEcCtD
Brinzolamide—CA12—Metabolism—RRM2—urinary bladder cancer	0.000289	0.00199	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—HPGDS—urinary bladder cancer	0.000289	0.00199	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000289	0.00199	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000289	0.00199	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ENO2—urinary bladder cancer	0.000289	0.00199	CbGpPWpGaD
Brinzolamide—Headache—Doxorubicin—urinary bladder cancer	0.000287	0.000441	CcSEcCtD
Brinzolamide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000283	0.00195	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.00028	0.00193	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTT1—urinary bladder cancer	0.00028	0.00193	CbGpPWpGaD
Brinzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000275	0.0019	CbGpPWpGaD
Brinzolamide—Nausea—Doxorubicin—urinary bladder cancer	0.000272	0.000419	CcSEcCtD
Brinzolamide—CA1—Metabolism—TYMP—urinary bladder cancer	0.000271	0.00187	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—HPGDS—urinary bladder cancer	0.000267	0.00185	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ENO2—urinary bladder cancer	0.000267	0.00185	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NAT2—urinary bladder cancer	0.000267	0.00184	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000266	0.00184	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000259	0.00179	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NQO1—urinary bladder cancer	0.000256	0.00176	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000256	0.00176	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NQO1—urinary bladder cancer	0.000249	0.00172	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NQO1—urinary bladder cancer	0.000249	0.00172	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000245	0.00169	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000242	0.00167	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000238	0.00164	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000233	0.00161	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NQO1—urinary bladder cancer	0.000233	0.00161	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—RRM2—urinary bladder cancer	0.00023	0.00159	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—RRM2—urinary bladder cancer	0.000221	0.00152	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000218	0.0015	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NAT2—urinary bladder cancer	0.000216	0.00149	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NQO1—urinary bladder cancer	0.000216	0.00149	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTP1—urinary bladder cancer	0.000213	0.00147	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000213	0.00147	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000213	0.00147	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000212	0.00146	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000212	0.00146	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000209	0.00144	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTP1—urinary bladder cancer	0.000208	0.00143	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTP1—urinary bladder cancer	0.000208	0.00143	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000207	0.00143	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000207	0.00143	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000204	0.00141	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000204	0.00141	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—TYMS—urinary bladder cancer	0.000198	0.00137	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000198	0.00137	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000196	0.00135	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NCOR1—urinary bladder cancer	0.000196	0.00135	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTM1—urinary bladder cancer	0.000196	0.00135	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000196	0.00135	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTP1—urinary bladder cancer	0.000194	0.00134	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000194	0.00134	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—TYMS—urinary bladder cancer	0.000193	0.00133	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—TYMS—urinary bladder cancer	0.000193	0.00133	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTM1—urinary bladder cancer	0.000191	0.00132	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NCOR1—urinary bladder cancer	0.000191	0.00132	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTM1—urinary bladder cancer	0.000191	0.00132	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NCOR1—urinary bladder cancer	0.000191	0.00132	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.00019	0.00131	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GPX1—urinary bladder cancer	0.000188	0.0013	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—RRM2—urinary bladder cancer	0.000186	0.00128	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ERCC2—urinary bladder cancer	0.000184	0.00127	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GPX1—urinary bladder cancer	0.000183	0.00126	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GPX1—urinary bladder cancer	0.000183	0.00126	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—TYMS—urinary bladder cancer	0.00018	0.00124	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—TYMS—urinary bladder cancer	0.00018	0.00124	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTP1—urinary bladder cancer	0.00018	0.00124	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ERCC2—urinary bladder cancer	0.00018	0.00124	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ERCC2—urinary bladder cancer	0.00018	0.00124	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000178	0.00123	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000178	0.00123	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTM1—urinary bladder cancer	0.000178	0.00123	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NCOR1—urinary bladder cancer	0.000178	0.00123	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—MTHFR—urinary bladder cancer	0.000173	0.0012	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ENO2—urinary bladder cancer	0.000172	0.00119	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000172	0.00119	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000172	0.00119	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GPX1—urinary bladder cancer	0.000171	0.00118	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GPX1—urinary bladder cancer	0.000171	0.00118	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.00017	0.00117	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—MTHFR—urinary bladder cancer	0.000169	0.00116	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—MTHFR—urinary bladder cancer	0.000169	0.00116	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ERCC2—urinary bladder cancer	0.000168	0.00116	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000168	0.00116	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—TYMS—urinary bladder cancer	0.000167	0.00115	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000167	0.00115	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NCOR1—urinary bladder cancer	0.000165	0.00114	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTM1—urinary bladder cancer	0.000165	0.00114	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NQO1—urinary bladder cancer	0.000165	0.00114	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000165	0.00114	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GPX1—urinary bladder cancer	0.000158	0.00109	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NQO1—urinary bladder cancer	0.000158	0.00109	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MTHFR—urinary bladder cancer	0.000158	0.00109	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000158	0.00109	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ERCC2—urinary bladder cancer	0.000155	0.00107	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000148	0.00102	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—MTHFR—urinary bladder cancer	0.000146	0.00101	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000143	0.000989	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—urinary bladder cancer	0.000141	0.000969	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NQO1—urinary bladder cancer	0.000139	0.000958	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000137	0.000948	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—urinary bladder cancer	0.000137	0.000945	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—urinary bladder cancer	0.000137	0.000945	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CREBBP—urinary bladder cancer	0.000135	0.000931	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TYMS—urinary bladder cancer	0.000133	0.00092	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000132	0.000909	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000132	0.000909	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000132	0.000909	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CREBBP—urinary bladder cancer	0.000132	0.000907	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CREBBP—urinary bladder cancer	0.000132	0.000907	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—urinary bladder cancer	0.000128	0.000882	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000128	0.000882	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000128	0.000882	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000126	0.000872	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000126	0.000872	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000126	0.000871	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000124	0.000855	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CREBBP—urinary bladder cancer	0.000123	0.000847	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000123	0.000847	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TYMS—urinary bladder cancer	0.000123	0.000845	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000121	0.000836	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000121	0.000836	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000121	0.000835	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000119	0.000819	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—urinary bladder cancer	0.000118	0.000817	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000116	0.000803	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GPX1—urinary bladder cancer	0.000116	0.0008	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—urinary bladder cancer	0.000116	0.000799	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000114	0.000787	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ERCC2—urinary bladder cancer	0.000114	0.000786	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CREBBP—urinary bladder cancer	0.000114	0.000785	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000112	0.000776	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—urinary bladder cancer	0.000112	0.00077	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—urinary bladder cancer	0.000111	0.000762	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TYMS—urinary bladder cancer	0.000108	0.000743	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—urinary bladder cancer	0.000108	0.000743	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—urinary bladder cancer	0.000108	0.000743	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—urinary bladder cancer	0.000107	0.000738	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOR1—urinary bladder cancer	0.000106	0.000735	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—urinary bladder cancer	0.000106	0.000735	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.000723	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000103	0.000713	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPX1—urinary bladder cancer	0.000102	0.000703	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—urinary bladder cancer	0.000101	0.000694	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—urinary bladder cancer	0.000101	0.000694	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ERCC2—urinary bladder cancer	0.0001	0.000691	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—urinary bladder cancer	9.64e-05	0.000665	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—urinary bladder cancer	9.44e-05	0.000651	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—urinary bladder cancer	9.41e-05	0.000649	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—urinary bladder cancer	9.39e-05	0.000648	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—urinary bladder cancer	9.39e-05	0.000648	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—urinary bladder cancer	9.32e-05	0.000643	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—EP300—urinary bladder cancer	9.19e-05	0.000634	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CREBBP—urinary bladder cancer	9.07e-05	0.000626	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—urinary bladder cancer	9.05e-05	0.000625	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—EP300—urinary bladder cancer	8.96e-05	0.000618	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—EP300—urinary bladder cancer	8.96e-05	0.000618	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—urinary bladder cancer	8.77e-05	0.000605	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—urinary bladder cancer	8.77e-05	0.000605	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CREBBP—urinary bladder cancer	8.7e-05	0.0006	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—urinary bladder cancer	8.68e-05	0.000599	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—EP300—urinary bladder cancer	8.36e-05	0.000577	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—EP300—urinary bladder cancer	8.36e-05	0.000577	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CREBBP—urinary bladder cancer	8.34e-05	0.000575	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—urinary bladder cancer	8.12e-05	0.00056	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—EP300—urinary bladder cancer	7.75e-05	0.000534	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—urinary bladder cancer	7.63e-05	0.000526	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—urinary bladder cancer	7.43e-05	0.000512	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CREBBP—urinary bladder cancer	7.33e-05	0.000506	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—urinary bladder cancer	7.12e-05	0.000491	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.99e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—urinary bladder cancer	6.83e-05	0.000471	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.62e-05	0.000457	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.62e-05	0.000457	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—urinary bladder cancer	6.48e-05	0.000447	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—urinary bladder cancer	6.21e-05	0.000428	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—EP300—urinary bladder cancer	6.18e-05	0.000426	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.06e-05	0.000418	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—urinary bladder cancer	6e-05	0.000414	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—urinary bladder cancer	5.96e-05	0.000411	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—EP300—urinary bladder cancer	5.92e-05	0.000409	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—EP300—urinary bladder cancer	5.68e-05	0.000392	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.45e-05	0.000376	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—urinary bladder cancer	5.24e-05	0.000361	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.15e-05	0.000355	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.02e-05	0.000346	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—EP300—urinary bladder cancer	4.99e-05	0.000344	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.01e-05	0.000277	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.63e-05	0.00025	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.13e-05	0.000216	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.9e-05	0.0002	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.9e-05	0.0002	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.81e-05	0.000194	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.34e-05	0.000161	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.95e-05	0.000135	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.81e-05	0.000125	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.79e-05	0.000124	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.79e-05	0.000124	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.72e-05	0.000118	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	0.000116	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	0.000109	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.28e-05	8.86e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	8.51e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	6.97e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.81e-06	6.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.4e-06	5.8e-05	CbGpPWpGaD
